| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 01/05/2011 | CN101933898A New pyritinol hydrochloride injection |
| 01/05/2011 | CN101933743A Traditional Chinese medical health pillow |
| 01/05/2011 | CN101933742A Prescription of great-forest fragrant pillow filling |
| 01/05/2011 | CN101313814B Health-care bedding and its making method |
| 01/05/2011 | CN101269160B Chinese medicinal composition for treating trigeminal neuralgia |
| 01/05/2011 | CN101195646B Production method of stilbene glycoside extract |
| 01/04/2011 | US7863475 5-[3-(2,6-Dimethylbenzyloxy)-phenyl]-pent-4-enoic acid ethyl ester; insulin resistance syndrome, diabetes, cachexia, hyperlipidemia, fatty liver disease, obesity, atherosclerosis, arteriosclerosis; side effects reduction; orally active |
| 01/04/2011 | US7863446 Heterocycles |
| 01/04/2011 | US7863445 2-((4,6-dimethoxy)pyrimidin-2-yl-),3-(methoxy-), 3,3-(diphenyl)propionic acid; antihypotensive agents; pulmonary hypertension, mycocardial necrosis; renal failure; brain disorders; antispasmodic agents; antiischemic agents; coagulants; asthma; atherosclerosis; restenosis; Raynaud's syndrome |
| 01/04/2011 | US7863327 Chemopreventative treatment of diseases such as cancer, Alzheimer's disease, Parkinson's disease, inflammatory bowel disease, and multiple sclerosis |
| 01/04/2011 | US7863312 Pyrazolidinone derivatives, e.g., 4-[2-(2-(3-hydroxyoctyl)-5-oxopyrazolidin-1-yl)ethyl]benzoic acid; treating preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, (pre)eclampsia, or eosinophil disorders |
| 01/04/2011 | US7863296 a mixture of N-(1-methylpiperidin-4-yl)-N-(4-fluorophenylmethyl)-N'-(4-(2-methylpropyloxy)phenylmethyl)carbamide and antiinsomnia drug, used for treating sleep and psychological disorders |
| 01/04/2011 | US7863289 Compounds and methods for kinase modulation, and indications therefor |
| 01/04/2011 | US7863271 2-aminobenzoxazole carboxamides as 5HT3 modulators |
| 01/04/2011 | US7863247 Prevention of fetal alcohol syndrome and neuronal cell death with ADNF polypeptides |
| 01/04/2011 | CA2640591C Use of 5-ht5-ligands in the treatment of neurodegenerative and neuropsychiatric disturbances |
| 01/04/2011 | CA2577667C 3-substituted-5- and 6-aminoalkyl indole-2-carboxylic acid amides and related analogs as inhibitors of casein kinase ie |
| 01/04/2011 | CA2558191C Composition containing benzamidine derivative and method for stabilizing benzamidine derivative |
| 01/04/2011 | CA2555331C Therapeutic agents |
| 01/04/2011 | CA2532631C Nasal pharmaceutical composition of piribedil |
| 01/04/2011 | CA2505555C Spirocyclic cyclohexane derivatives |
| 01/04/2011 | CA2491871C Novel complexes of fatty acid esters of polyhydroxyalkanes and pyridine carboxy derivatives |
| 01/04/2011 | CA2479362C N-sulfonylurea apoptosis promoters |
| 01/04/2011 | CA2468517C Thioether substituted imidazoquinolines |
| 01/04/2011 | CA2462953C Substituted 4-phenyl-4-[1h-imidazol-2-yl]-piperidine derivatives and their use as selective non-peptide delta opioid agonists |
| 01/04/2011 | CA2460822C Aralkyltetrahydropyridines, their preparation and pharmaceutical compositions containing same |
| 01/04/2011 | CA2458533C Imidazole derivates as anti-inflammatory agents |
| 01/04/2011 | CA2454703C Novel thiophene carboxamide derivatives |
| 01/04/2011 | CA2446828C Adenosine a1 receptor antagonists for treating hypoxia-induced learning and memory impairment |
| 01/04/2011 | CA2430279C Use of 6-dimethylaminomethyl-1-phenyl-cyclohexane compounds for treatment of urinary incontinence |
| 01/04/2011 | CA2429312C Novel pyridine-substituted pyrazolopyridine derivatives |
| 01/04/2011 | CA2415275C Improved methods of synthesis for 9-substituted hypoxanthine derivatives |
| 01/04/2011 | CA2404128C Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 01/04/2011 | CA2400959C Composition for the prevention and/or treatment of vascular diseases, comprising propionyl l-carnitine and coenzyme q10 |
| 01/04/2011 | CA2397798C Substituted pyridine compounds useful for controlling chemical synaptic transmission |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 01/04/2011 | CA2388609C Oxcarbazepine formulations for administration with or without food |
| 01/04/2011 | CA2375008C Phenoxypropylamine compounds |
| 01/04/2011 | CA2354154C A.beta.-peptide screening assay |
| 01/04/2011 | CA2333317C Stable oil-in-glycerin emulsion |
| 01/04/2011 | CA2306875C Nutritional supplement for cerebral metabolic insufficiencies |
| 01/04/2011 | CA2306093C Heteroaryl diazacycloalkanes as cholinergic ligands at nicotinic acetylcholine receptors |
| 01/04/2011 | CA2281272C 2-amino-bicyclo[3.1.0]hexane-2,6-dicarboxylic acid derivatives and a process for preparation thereof |
| 01/04/2011 | CA2163439C Methods of using bcl-2 for the therapeutic treatment and prevention of diseases |
| 01/04/2011 | CA2101774C Test and model for alzheimer's disease |
| 12/30/2010 | US20100333216 Non-human gene-disrupted animal with disrupted Adam11 gene |
| 12/30/2010 | US20100331999 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331420 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331419 Combination Therapies for the Treatment of Obesity |
| 12/30/2010 | US20100331417 Treatment of neural diseases or conditions |
| 12/30/2010 | US20100331414 Crystal comprising (2r)-2-propyloctanoic acid and amine |
| 12/30/2010 | US20100331402 Prophylactic or therapeutic agent for attention deficit/hyperactivity disorder |
| 12/30/2010 | US20100331388 Crystalline Duloxetine Hydrochloride |
| 12/30/2010 | US20100331386 Enantiomers of spiro-oxindole compounds and their uses as therapeutic agents |
| 12/30/2010 | US20100331385 Pyrazole urea derivatives used as kinase inhibitors |
| 12/30/2010 | US20100331384 Guanidine based compounds |
| 12/30/2010 | US20100331381 Substituted Phenylureas and Phenylamides as Vanilloid Receptor Ligands |
| 12/30/2010 | US20100331380 Compounds, Compositions, and Methods for the Treatment of Beta-Amyloid Diseases and Synucleinopathies |
| 12/30/2010 | US20100331367 N-aryl-n-piperidin-4-yl-propionamide derivatives and their use as opioid receptor ligands |
| 12/30/2010 | US20100331363 Treatment of mitochondrial disorders using a farnesyl transferase inhibitor |
| 12/30/2010 | US20100331357 Pharmaceutical composition |
| 12/30/2010 | US20100331354 Intranasal Opioid Compositions |
| 12/30/2010 | US20100331353 3,9-diazaspiro[5,5]undecane amides and ureas and methods of use thereof |
| 12/30/2010 | US20100331350 Inhibitors of bruton's tyrosine kinase |
| 12/30/2010 | US20100331347 (en) 3-sulfonyl-pyrazolo[1,5-a] pyrimidines / antagonists of serotonin 5-ht6 receptors, methods for the production and the use thereof |
| 12/30/2010 | US20100331346 Beta-amino acid derivatives for treatment of diabetes |
| 12/30/2010 | US20100331345 Derivatives of substituted tartaric acid and usage for preparing beta-secretase inhibitors |
| 12/30/2010 | US20100331344 Modulators of ATP-Binding Cassette Transporters |
| 12/30/2010 | US20100331343 Novel triazole derivatives as ghrelin analogue ligands of growth hormone secretagogue receptors |
| 12/30/2010 | US20100331342 Immuno Inhibitory Pyrazolone Compounds |
| 12/30/2010 | US20100331341 2-carboxamide-7-piperazinyl-benzofuran derivatives 774 |
| 12/30/2010 | US20100331338 Glucokinase Activators |
| 12/30/2010 | US20100331337 Quercetin-Containing Compositions |
| 12/30/2010 | US20100331335 Inhibitors of Jun N-Terminal Kinase |
| 12/30/2010 | US20100331333 Imidazo [1,2-B] Pyridazine Compounds |
| 12/30/2010 | US20100331332 Methods for treating drug addiction and improving addiction-related behavior |
| 12/30/2010 | US20100331330 Methods and compositions for treating ischemic stroke |
| 12/30/2010 | US20100331329 Benzamide derivatives useful as histone deacetylase inhibitors |
| 12/30/2010 | US20100331325 Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives |
| 12/30/2010 | US20100331323 Synthesis and regioselective substitution of 6-halo- and 6-alkoxy nicotine derivatives |
| 12/30/2010 | US20100331313 Thiazole Derivatives as Protein Kinase Inhibitors |
| 12/30/2010 | US20100331312 Modulators of the histamine h3 receptor useful for the treatment of disorders related thereto |
| 12/30/2010 | US20100331310 Bicycloamine derivatives |
| 12/30/2010 | US20100331304 Compounds Which Modulate The CB2 Receptor |
| 12/30/2010 | US20100331297 Modulation of protein trafficking |
| 12/30/2010 | US20100331295 Modulators of lxr |
| 12/30/2010 | US20100331294 4-substituted-2-amino-pyrimidine derivatives |
| 12/30/2010 | US20100331284 Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system |
| 12/30/2010 | US20100331275 Supporting activities of daily living |
| 12/30/2010 | US20100331268 Nitrated Lipids and Methods of Making and Using Thereof |
| 12/30/2010 | US20100331262 PEPTIDE VACCINE USING MIMIC MOLECULES OF AMYLOID Beta PEPTIDE |
| 12/30/2010 | US20100331259 Use of a neurotoxic component of a clostridium botulinum toxin complex to reduce or prevent side effects. |
| 12/30/2010 | US20100331258 memory in subjects with mini-mental state examination of 24-26 |
| 12/30/2010 | US20100331239 Cd14 and peptides thereof for protection of cells against cell death |
| 12/30/2010 | US20100331237 Gag binding proteins |
| 12/30/2010 | US20100331236 Cyclic peptides as g-protein coupled receptor antagonists |
| 12/30/2010 | US20100331234 Aminoalcohol lipidoids and uses thereof |
| 12/30/2010 | US20100330673 Methods of making enhanced, autologous fat grafts |
| 12/30/2010 | US20100330586 Method for identifying compounds for treatment of pain |
| 12/30/2010 | US20100330210 Ghrelin production promoter |